Page last updated: 2024-11-02

pindolol and Chronic Insomnia

pindolol has been researched along with Chronic Insomnia in 2 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Research Excerpts

ExcerptRelevanceReference
" The patient took 20 mg daily for five days and then decided, on her own, to decrease the dosage after experiencing insomnia, a common adverse effect of duloxetine."1.34Facial flushing associated with duloxetine use. ( Ezzo, DC; Patel, PN, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Serretti, A1
Cusin, C1
Benedetti, F1
Mandelli, L1
Pirovano, A1
Zanardi, R1
Colombo, C1
Smeraldi, E1
Ezzo, DC1
Patel, PN1

Trials

1 trial available for pindolol and Chronic Insomnia

ArticleYear
Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism.
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2005, Aug-05, Volume: 137B, Issue:1

    Topics: Adult; Aged; Antidepressive Agents; CLOCK Proteins; Double-Blind Method; Drug Therapy, Combination;

2005

Other Studies

1 other study available for pindolol and Chronic Insomnia

ArticleYear
Facial flushing associated with duloxetine use.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Mar-01, Volume: 64, Issue:5

    Topics: Adult; Botulinum Toxins, Type A; Capsules; Duloxetine Hydrochloride; Female; Flushing; Humans; Migra

2007